Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates

– Phase 3 ELEVATE UC 52 and 12 on course for Q1 2022 topline data readout PARK CITY, Utah --(BUSINESS WIRE)--Feb. 23, 2022-- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2021 .